Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Hernö Gin Q3 pretax profit falls 15% to SEK 2.3 million; Q3 net sales rise 13% to SEK 14.7 million

Hernö Gin Q3 pretax profit falls 15% to SEK 2.3 million; Q3 net sales rise 13% to SEK 14.7 million

BitgetBitget2026/10/21 06:09
  • Hernö Gin’s third-quarter pretax profit fell 15% to SEK 2.3 million, while net sales rose 13% to SEK 14.7 million.
  • January–September pretax profit dropped 27% to SEK 4.1 million, while net sales climbed 23% to SEK 42.4 million.
  • Third-quarter visitor-business net sales jumped 40% to SEK 7.3 million, with the Gothenburg bar contributing to growth.
  • Investment in establishing the Gothenburg operation weighed on earnings; management is increasing marketing investment in Sweden, selected export markets and border trade.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Herno Gin AB published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53